Collagenous colitis following SARS‐Cov2 mRNA vaccination

A healthy 49‐year‐old female developed intractable watery diarrhea after the Pfizer SARS‐Cov2 mRNA vaccination. She was subsequently diagnosed with collagenous colitis (CC). She had no prior history of medication use, suggesting of vaccination being the trigger. CC or lymphocytic colitis should be c...

Descripción completa

Detalles Bibliográficos
Autores principales: Iketani, Momoko, Takada, Yutaka, Itani, Toshinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134757/
https://www.ncbi.nlm.nih.gov/pubmed/37125246
http://dx.doi.org/10.1002/jgh3.12885
_version_ 1785031826320916480
author Iketani, Momoko
Takada, Yutaka
Itani, Toshinao
author_facet Iketani, Momoko
Takada, Yutaka
Itani, Toshinao
author_sort Iketani, Momoko
collection PubMed
description A healthy 49‐year‐old female developed intractable watery diarrhea after the Pfizer SARS‐Cov2 mRNA vaccination. She was subsequently diagnosed with collagenous colitis (CC). She had no prior history of medication use, suggesting of vaccination being the trigger. CC or lymphocytic colitis should be considered as differential diagnoses for persistent watery diarrhea after SARS‐Cov2 mRNA vaccination.
format Online
Article
Text
id pubmed-10134757
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-101347572023-04-28 Collagenous colitis following SARS‐Cov2 mRNA vaccination Iketani, Momoko Takada, Yutaka Itani, Toshinao JGH Open Case Report A healthy 49‐year‐old female developed intractable watery diarrhea after the Pfizer SARS‐Cov2 mRNA vaccination. She was subsequently diagnosed with collagenous colitis (CC). She had no prior history of medication use, suggesting of vaccination being the trigger. CC or lymphocytic colitis should be considered as differential diagnoses for persistent watery diarrhea after SARS‐Cov2 mRNA vaccination. Wiley Publishing Asia Pty Ltd 2023-03-10 /pmc/articles/PMC10134757/ /pubmed/37125246 http://dx.doi.org/10.1002/jgh3.12885 Text en © 2023 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Iketani, Momoko
Takada, Yutaka
Itani, Toshinao
Collagenous colitis following SARS‐Cov2 mRNA vaccination
title Collagenous colitis following SARS‐Cov2 mRNA vaccination
title_full Collagenous colitis following SARS‐Cov2 mRNA vaccination
title_fullStr Collagenous colitis following SARS‐Cov2 mRNA vaccination
title_full_unstemmed Collagenous colitis following SARS‐Cov2 mRNA vaccination
title_short Collagenous colitis following SARS‐Cov2 mRNA vaccination
title_sort collagenous colitis following sars‐cov2 mrna vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134757/
https://www.ncbi.nlm.nih.gov/pubmed/37125246
http://dx.doi.org/10.1002/jgh3.12885
work_keys_str_mv AT iketanimomoko collagenouscolitisfollowingsarscov2mrnavaccination
AT takadayutaka collagenouscolitisfollowingsarscov2mrnavaccination
AT itanitoshinao collagenouscolitisfollowingsarscov2mrnavaccination

Ejemplares similares